| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CNCR.22534 |
| P698 | PubMed publication ID | 17311344 |
| P50 | author | Alan R. Kristal | Q55188868 |
| P2093 | author name string | Daniel W Lin | |
| Janet L Stanford | |||
| Ilir Agalliu | |||
| Zhihong Gong | |||
| P2860 | cites work | Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults | Q28131763 |
| Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms | Q29615455 | ||
| Serum immunoreactive-leptin concentrations in normal-weight and obese humans | Q29617230 | ||
| Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. | Q31018353 | ||
| Leptin and prostate cancer | Q31912917 | ||
| Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy | Q34285704 | ||
| Prostate carcinogenesis and inflammation: emerging insights. | Q35925066 | ||
| The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer | Q36017021 | ||
| Prostate cancer and body size at different ages: an Italian multicentre case-control study | Q36694225 | ||
| Biological action of leptin as an angiogenic factor | Q38333557 | ||
| Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy | Q39724803 | ||
| Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy | Q40431540 | ||
| Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers | Q40900660 | ||
| Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis | Q41899984 | ||
| Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group | Q42616120 | ||
| High-grade prostate cancer is associated with low serum testosterone levels | Q43576700 | ||
| Effect of obesity and body fat distribution on sex hormones and insulin in men. | Q44107806 | ||
| Leptin influences cellular differentiation and progression in prostate cancer | Q44357432 | ||
| Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results | Q44644044 | ||
| Diet, obesity, and risk of fatal prostate cancer | Q46324199 | ||
| Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. | Q46491237 | ||
| Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins | Q46782139 | ||
| Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy | Q47366439 | ||
| Chemokines control fat accumulation and leptin secretion by cultured human adipocytes | Q57076426 | ||
| Estimation of Regression Coefficients When Some Regressors are not Always Observed | Q57310639 | ||
| Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial | Q58394513 | ||
| Overweight and mortality | Q69614660 | ||
| Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging | Q69737582 | ||
| Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men | Q74238943 | ||
| Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center | Q81044159 | ||
| Stronger association between obesity and biochemical progression after radical prostatectomy among men treated in the last 10 years | Q81662282 | ||
| Obesity and survival after radical prostatectomy: A 10-year prospective cohort study | Q83989911 | ||
| Simultaneous Statistical Inference | Q107179976 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| prostate cancer | Q181257 | ||
| cancer research | Q3421914 | ||
| diagnosis | Q16644043 | ||
| cancer diagnosis | Q110324059 | ||
| cancer metastasis | Q120912394 | ||
| P304 | page(s) | 1192-1202 | |
| P577 | publication date | 2007-03-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men | |
| P478 | volume | 109 |
| Q37727876 | A review of laparoscopic sleeve gastrectomy for morbid obesity |
| Q37156735 | A study of caloric restriction versus standard diet in overweight men with newly diagnosed prostate cancer: a randomized controlled trial |
| Q39411380 | Adiponectin inhibits oxidative stress in human prostate carcinoma cells |
| Q28080748 | Adipose tissue dysfunction and its effects on tumor metabolism |
| Q87692438 | Association among metabolic syndrome, inflammation, and survival in prostate cancer |
| Q39090001 | Association of Obesity-Related Hemodilution of Prostate-Specific Antigen, Dihydrotestosterone, and Testosterone |
| Q34007448 | Association of body mass index and prostate cancer mortality |
| Q33728225 | Associations between an obesity related genetic variant (FTO rs9939609) and prostate cancer risk |
| Q41407126 | Associations of pre-diagnostic body mass index with overall and cancer-specific mortality in a large Austrian cohort |
| Q38692737 | Body mass index and mortality in prostate cancer patients: a dose-response meta-analysis |
| Q47173681 | Body mass index and weight change in men with prostate cancer: progression and mortality |
| Q88601345 | Body mass index is an independent predictor of Clavien-Dindo grade 3 complications in patients undergoing robot assisted radical prostatectomy with extensive pelvic lymph node dissection |
| Q24625223 | Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis |
| Q29614869 | Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies |
| Q34132305 | Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases |
| Q40772258 | Can body mass index predict survival outcomes in patients treated with radical nephroureterectomy for upper-tract urothelial carcinoma? |
| Q38471556 | Circulating steroid hormones in prostate carcinogenesis. Part 2: Estrogens |
| Q33751144 | Combination of physical activity, nutrition, or other metabolic factors and vaccine response |
| Q36979100 | Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer |
| Q24594183 | Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial |
| Q46683703 | Effect of BMI on primary treatment of prostate cancer |
| Q37361333 | Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States. |
| Q34315768 | Energetics in colorectal and prostate cancer |
| Q55468609 | Fatty Acids and Calcium Regulation in Prostate Cancer. |
| Q37355770 | Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial |
| Q26765503 | Fortifying the Treatment of Prostate Cancer with Physical Activity |
| Q37245092 | Health risk behaviors and prostate specific antigen awareness among men in California |
| Q38972634 | High animal fat intake enhances prostate cancer progression and reduces glutathione peroxidase 3 expression in early stages of TRAMP mice |
| Q37120159 | Hyperglycemia and prostate cancer recurrence in men treated for localized prostate cancer |
| Q35513889 | IL-17 and insulin/IGF1 enhance adhesion of prostate cancer cells to vascular endothelial cells through CD44-VCAM-1 interaction |
| Q58790804 | Impact of Body Mass Index on Oncological Outcomes of Prostate Cancer Patients after Radical Prostatectomy |
| Q45891100 | Impact of body mass index on outcomes of laparoscopic radical prostatectomy with long-term follow-up |
| Q35985620 | Impact of obesity on outcomes after definitive dose-escalated intensity-modulated radiotherapy for localized prostate cancer |
| Q91776602 | Impact of peri-prostatic fat measurements using MRI on the prediction of prostate cancer with transrectal ultrasound-guided biopsy |
| Q37127379 | Influence of diet on metastasis and tumor dormancy. |
| Q37887276 | Insulin-like growth factor pathway: a link between androgen deprivation therapy (ADT), insulin resistance, and disease progression in patients with prostate cancer? |
| Q53456475 | Is body mass index associated with pathological outcomes after radical prostatectomy in Korean men? |
| Q84567489 | Longitudinal assessment of BMI in relation to ADT use among early stage prostate cancer survivors |
| Q93182748 | Management of bone and metabolic effects of androgen deprivation therapy |
| Q38627406 | Metabolic Syndrome and Prostate Cancer: a Review of Complex Interplay Amongst Various Endocrine Factors in the Pathophysiology and Progression of Prostate Cancer |
| Q35433102 | Metabolic complications and increased cardiovascular risks as a result of androgen deprivation therapy in men with prostate cancer |
| Q41732768 | Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone. |
| Q35112929 | Nanocytological field carcinogenesis detection to mitigate overdiagnosis of prostate cancer: a proof of concept study |
| Q58282670 | Obesity and cancer: Pathophysiological and biological mechanisms |
| Q34617851 | Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31. |
| Q36967312 | Obesity and prostate cancer mortality |
| Q37636973 | Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database |
| Q92963543 | Obesity at Diagnosis and Prostate Cancer Prognosis and Recurrence Risk Following Primary Treatment by Radical Prostatectomy |
| Q52677839 | Obesity paradox in prostate cancer: increased body mass index was associated with decreased risk of metastases after surgery in 13,667 patients. |
| Q37692208 | Obesity, age, ethnicity, and clinical features of prostate cancer patients |
| Q82845664 | Obesity-related cancer: an emerging need for more education |
| Q39396694 | Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells |
| Q28076686 | Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression |
| Q37641565 | Oral kanglaite injection (KLTI) attenuates the lung cancer-promoting effect of high-fat diet (HFD)-induced obesity |
| Q42415229 | PSA mass as a marker of prostate cancer progression after radical prostatectomy. |
| Q34845451 | Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis |
| Q42615368 | Preoperative weight change and risk of adverse outcome following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database |
| Q43882657 | Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation: analysis of trends over time |
| Q52913335 | Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression. |
| Q90016426 | Randomized trial evaluating the role of weight loss in overweight and obese men with early stage prostate Cancer on active surveillance: Rationale and design of the Prostate Cancer Active Lifestyle Study (PALS) |
| Q37144096 | Role of stearoyl-CoA desaturases in obesity and the metabolic syndrome |
| Q85103504 | Smoking, Obesity, and Statin Therapy in the Prognosis of Prostate Cancer |
| Q39136489 | Socioeconomic position and mortality among patients with prostate cancer: influence of mediating factors |
| Q35713080 | The Exercising Together project: design and recruitment for a randomized, controlled trial to determine the benefits of partnered strength training for couples coping with prostate cancer |
| Q33992032 | The anticancer gene ORCTL3 targets stearoyl-CoA desaturase-1 for tumour-specific apoptosis |
| Q37678989 | The effect of androgen deprivation therapy on body composition in men with prostate cancer: systematic review and meta-analysis. |
| Q41767239 | The effects of metabolic conditions on prostate cancer incidence over 15 years of follow-up: results from the Olmsted County Study |
| Q33404355 | The isolation and identification of apolipoprotein C-I in hormone-refractory prostate cancer using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry |
| Q34072520 | The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes |
| Q46522792 | The relationship of body mass index and serum testosterone with disease outcomes in men with castration-resistant metastatic prostate cancer. |
| Q35614869 | Total pelvic exenteration for rectal cancer: outcomes and prognostic factors |
| Q37910709 | Urological aspects of the metabolic syndrome |
| Q24628345 | Vitamin D pathway gene variants and prostate cancer prognosis |
Search more.